| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 128,053 | 112,230 | 136,015 | 131,253 | | Cost of Revenue | 74,963 | 20,181 | 91,676 | 92,531 | | | Gross Profit | 53,090 | 92,049 | 44,339 | 38,722 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (76) | 63,283 | 13,011 | 5,750 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 13,034 | 12,739 | 12,673 | 12,687 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,677 | 16,027 | 18,655 | 20,285 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,474 | 1,246 | 1,562 | (3,638) | | Earnings Before Interest And Taxes | 31,245 | 17,255 | 20,141 | (2,481) | | Interest Expense | 16,338 | 9,628 | 9,228 | 5,069 | | Income Before Tax | 14,907 | 7,627 | 10,913 | (7,550) | | Income Tax Expense | 16,361 | 18 | 76 | 3,843 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,548) | 7,627 | 10,913 | 7,735 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,828 | 7,627 | 10,913 | 7,735 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,828 | $7,627 | $10,913 | $7,735 |
|
1.36% Nasdaq 
Income Statement
